MC38-Stk11 KO
Strain Information
表現型データ
Fig1. Stk11 expression on in vitro cultured cells of MC38-Stk11-KO.
Fig2. In vivo validation of MC38-Stk11-KO in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-Stk11-KO subcutaneously at 1×106 cells/mouse inoculum for tumor development. The day of vaccination for mice is defined as Day 0, and tumor measurement and weight measurement begin on the 3rd day after vaccination, twice a week.
Fig3. In vivo validation of MC38-Stk11-KO in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-Stk11-KO subcutaneously at 1×106 cells/mouse inoculum for tumor development. The day of vaccination for mice is defined as Day 0, and tumor measurement and weight measurement begin on the 3rd day after vaccination, twice a week.
Fig4. Stk11 expression in tumors after in vivo growth of MC38-Stk11-KO in wild type C57BL/6 mice. When the mean tumor volume (MTV) reaches 500-800 mm3, take one tube from each group and send it to Western Blot for testing (Markers: mGapdh, mStk11); When the MTV reaches 1000-1500mm3, take 2 tubes from each group and send them to Western Blot for testing (Markers: mGapdh, mStk11). A, the MTV reaches 800 mm3. B, the MTV reaches 1500 mm3.
関連の系統
あなたも好きかも
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
詳細At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
詳細